Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma

SIMPLE SUMMARY: Osteosarcoma is a bone cancer with a poor prognosis. This is, in part, due to resistance to current standard-of-care chemotherapeutic treatment. As personalized treatment plans become more widely utilized, the role of patient-specific genome markers may serve to identify individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Adam M., Ferdjallah, Asmaa, Moore, Elise, Kim, Daniel C., Nath, Aritro, Greengard, Emily, Huang, R. Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538287/
https://www.ncbi.nlm.nih.gov/pubmed/34681828
http://dx.doi.org/10.3390/ijms222011168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538287/
https://www.ncbi.nlm.nih.gov/pubmed/34681828
http://dx.doi.org/10.3390/ijms222011168

Ejemplares similares